Medgend Icon







discontinued


Nexium FDA Approved Drugs

ESOMEPRAZOLE MAGNESIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O]
RX
-
eq 20mg base (oral capsule, delayed rel pellets)
eq 40mg base (oral capsule, delayed rel pellets)
Aurobindo Pharma LtdApr 21, 2016
Dr Reddys Labs LtdSep 25, 2015
Hetero Labs Ltd IiiSep 21, 2015
Ivax Sub Teva PharmsJan 26, 2015
Mylan Pharms IncAug 2, 2015
Torrent Pharms LtdOct 19, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESOMEPRAZOLE SODIUM [Esomeprazole SodiumC17H18N3O3SNa]
RX
-
eq 20mg base/vial (intravenous injectable)
eq 40mg base/vial (intravenous injectable)
Aurobindo Pharma LtdAug 10, 2016
Mylan Labs LtdMay 17, 2017
Sun Pharma GlobalMar 18, 2013
Accord HlthcareSep 25, 2015
Deva Holding AsMar 6, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NEXIUM [Esomeprazole Magnesium2C17H18N3O3SMg3H2O]
RX
-
eq 10mg base/packet (oral for suspension, delayed release)
eq 2.5mg base/packet (oral for suspension, delayed release)
eq 20mg base (oral capsule, delayed rel pellets)
eq 20mg base/packet (oral for suspension, delayed release)
eq 40mg base (oral capsule, delayed rel pellets)
eq 40mg base/packet (oral for suspension, delayed release)
eq 5mg base/packet (oral for suspension, delayed release)
Astrazeneca PharmsFeb 27, 2008
  • Pediatric use aged 1-11 years, gerd and erosive esophagitis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NEXIUM 24HR [Esomeprazole Magnesium2C17H18N3O3SMg3H2O]
Astrazeneca LpMar 28, 2014
  • Treatment of frequent heartburn by administering a gastric acid reducer.
  • Treatment of frequent heartburn by administering omeprazole according to claims 1-8.
  • Treatment of frequent heartburn by administering s-omeprazole trihydrate according to claims 1-3.
efficacy
4.5  (11)
side effects
1.1  (11)
danger
1.0  (10)

UNK


WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.